Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries.
BACKGROUND:Congenital toxoplasmosis is a serious but preventable and treatable disease. Gestational screening facilitates early detection and treatment of primary acquisition. Thus, fetal infection can be promptly diagnosed and treated and outcomes can be improved. METHODS:We tested 180 sera with th...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-06-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | http://europepmc.org/articles/PMC5501679?pdf=render |
| _version_ | 1818966197088026624 |
|---|---|
| author | Ian J Begeman Joseph Lykins Ying Zhou Bo Shiun Lai Pauline Levigne Kamal El Bissati Kenneth Boyer Shawn Withers Fatima Clouser A Gwendolyn Noble Peter Rabiah Charles N Swisher Peter T Heydemann Despina G Contopoulos-Ioannidis Jose G Montoya Yvonne Maldonado Raymund Ramirez Cindy Press Eileen Stillwaggon François Peyron Rima McLeod |
| author_facet | Ian J Begeman Joseph Lykins Ying Zhou Bo Shiun Lai Pauline Levigne Kamal El Bissati Kenneth Boyer Shawn Withers Fatima Clouser A Gwendolyn Noble Peter Rabiah Charles N Swisher Peter T Heydemann Despina G Contopoulos-Ioannidis Jose G Montoya Yvonne Maldonado Raymund Ramirez Cindy Press Eileen Stillwaggon François Peyron Rima McLeod |
| author_sort | Ian J Begeman |
| collection | DOAJ |
| description | BACKGROUND:Congenital toxoplasmosis is a serious but preventable and treatable disease. Gestational screening facilitates early detection and treatment of primary acquisition. Thus, fetal infection can be promptly diagnosed and treated and outcomes can be improved. METHODS:We tested 180 sera with the Toxoplasma ICT IgG-IgM point-of-care (POC) test. Sera were from 116 chronically infected persons (48 serotype II; 14 serotype I-III; 25 serotype I-IIIa; 28 serotype Atypical, haplogroup 12; 1 not typed). These represent strains of parasites infecting mothers of congenitally infected children in the U.S. 51 seronegative samples and 13 samples from recently infected persons known to be IgG/IgM positive within the prior 2.7 months also were tested. Interpretation was confirmed by two blinded observers. A comparison of costs for POC vs. commercial laboratory testing methods was performed. RESULTS:We found that this new Toxoplasma ICT IgG-IgM POC test was highly sensitive (100%) and specific (100%) for distinguishing IgG/IgM-positive from negative sera. Use of such reliable POC tests can be cost-saving and benefit patients. CONCLUSIONS:Our work demonstrates that the Toxoplasma ICT IgG-IgM test can function reliably as a point-of-care test to diagnose Toxoplasma gondii infection in the U.S. This provides an opportunity to improve maternal-fetal care by using approaches, diagnostic tools, and medicines already available. This infection has serious, lifelong consequences for infected persons and their families. From the present study, it appears a simple, low-cost POC test is now available to help prevent morbidity/disability, decrease cost, and make gestational screening feasible. It also offers new options for improved prenatal care in low- and middle-income countries. |
| first_indexed | 2024-12-20T13:29:04Z |
| format | Article |
| id | doaj.art-9f2617e55968471c9b68fa50a0fa5d9c |
| institution | Directory Open Access Journal |
| issn | 1935-2727 1935-2735 |
| language | English |
| last_indexed | 2024-12-20T13:29:04Z |
| publishDate | 2017-06-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Neglected Tropical Diseases |
| spelling | doaj.art-9f2617e55968471c9b68fa50a0fa5d9c2022-12-21T19:39:09ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352017-06-01116e000567010.1371/journal.pntd.0005670Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries.Ian J BegemanJoseph LykinsYing ZhouBo Shiun LaiPauline LevigneKamal El BissatiKenneth BoyerShawn WithersFatima ClouserA Gwendolyn NoblePeter RabiahCharles N SwisherPeter T HeydemannDespina G Contopoulos-IoannidisJose G MontoyaYvonne MaldonadoRaymund RamirezCindy PressEileen StillwaggonFrançois PeyronRima McLeodBACKGROUND:Congenital toxoplasmosis is a serious but preventable and treatable disease. Gestational screening facilitates early detection and treatment of primary acquisition. Thus, fetal infection can be promptly diagnosed and treated and outcomes can be improved. METHODS:We tested 180 sera with the Toxoplasma ICT IgG-IgM point-of-care (POC) test. Sera were from 116 chronically infected persons (48 serotype II; 14 serotype I-III; 25 serotype I-IIIa; 28 serotype Atypical, haplogroup 12; 1 not typed). These represent strains of parasites infecting mothers of congenitally infected children in the U.S. 51 seronegative samples and 13 samples from recently infected persons known to be IgG/IgM positive within the prior 2.7 months also were tested. Interpretation was confirmed by two blinded observers. A comparison of costs for POC vs. commercial laboratory testing methods was performed. RESULTS:We found that this new Toxoplasma ICT IgG-IgM POC test was highly sensitive (100%) and specific (100%) for distinguishing IgG/IgM-positive from negative sera. Use of such reliable POC tests can be cost-saving and benefit patients. CONCLUSIONS:Our work demonstrates that the Toxoplasma ICT IgG-IgM test can function reliably as a point-of-care test to diagnose Toxoplasma gondii infection in the U.S. This provides an opportunity to improve maternal-fetal care by using approaches, diagnostic tools, and medicines already available. This infection has serious, lifelong consequences for infected persons and their families. From the present study, it appears a simple, low-cost POC test is now available to help prevent morbidity/disability, decrease cost, and make gestational screening feasible. It also offers new options for improved prenatal care in low- and middle-income countries.http://europepmc.org/articles/PMC5501679?pdf=render |
| spellingShingle | Ian J Begeman Joseph Lykins Ying Zhou Bo Shiun Lai Pauline Levigne Kamal El Bissati Kenneth Boyer Shawn Withers Fatima Clouser A Gwendolyn Noble Peter Rabiah Charles N Swisher Peter T Heydemann Despina G Contopoulos-Ioannidis Jose G Montoya Yvonne Maldonado Raymund Ramirez Cindy Press Eileen Stillwaggon François Peyron Rima McLeod Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries. PLoS Neglected Tropical Diseases |
| title | Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries. |
| title_full | Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries. |
| title_fullStr | Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries. |
| title_full_unstemmed | Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries. |
| title_short | Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries. |
| title_sort | point of care testing for toxoplasma gondii igg igm using toxoplasma ict igg igm test with sera from the united states and implications for developing countries |
| url | http://europepmc.org/articles/PMC5501679?pdf=render |
| work_keys_str_mv | AT ianjbegeman pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT josephlykins pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT yingzhou pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT boshiunlai pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT paulinelevigne pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT kamalelbissati pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT kennethboyer pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT shawnwithers pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT fatimaclouser pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT agwendolynnoble pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT peterrabiah pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT charlesnswisher pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT petertheydemann pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT despinagcontopoulosioannidis pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT josegmontoya pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT yvonnemaldonado pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT raymundramirez pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT cindypress pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT eileenstillwaggon pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT francoispeyron pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries AT rimamcleod pointofcaretestingfortoxoplasmagondiiiggigmusingtoxoplasmaictiggigmtestwithserafromtheunitedstatesandimplicationsfordevelopingcountries |